Security key
26818M108
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 164,426,217
- Total 13F shares
- 49,732,095
- Share change
- +4,446,598
- Total reported value
- $576,377,450
- Put/Call ratio
- 5.9%
- Price per share
- $11.59
- Number of holders
- 112
- Value change
- +$50,130,248
- Number of buys
- 55
- Number of sells
- 41
Report period
Q4 2022
Institutions
112
Top holders
10
DYN full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Dyne Therapeutics, Inc. SEC filings
Dyne Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 26818M108
Recent filing periods:
Top shareholders of DYN - Dyne Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
5.4%
|
8,934,902
|
$113,473,000 | — | 30 Sep 2022 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
3%
|
4,951,303
|
$62,882,000 | — | 30 Sep 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
1.9%
|
3,184,200
|
$40,439,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
2,922,372
|
$37,114,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
2,525,067
|
$32,069,000 | — | 30 Sep 2022 | |
| WASATCH ADVISORS LP |
13F
|
Company |
1.4%
|
2,292,268
|
$29,112,000 | — | 30 Sep 2022 | |
| Logos Global Management LP |
13F
|
Company |
1.4%
|
2,287,321
|
$29,049,000 | — | 30 Sep 2022 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
1.4%
|
2,220,034
|
$28,194,000 | — | 30 Sep 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.1%
|
1,782,871
|
$22,643,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.91%
|
1,497,631
|
$19,020,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.81%
|
1,338,365
|
$16,997,000 | — | 30 Sep 2022 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.61%
|
1,000,000
|
$12,700,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.47%
|
765,953
|
$9,726,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.35%
|
578,880
|
$7,352,000 | — | 30 Sep 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
0.35%
|
577,642
|
$7,336,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
533,617
|
$6,776,000 | — | 30 Sep 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
525,000
|
$6,668,000 | — | 30 Sep 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.27%
|
450,000
|
$5,715,000 | — | 30 Sep 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.25%
|
413,624
|
$5,253,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
397,570
|
$5,049,000 | — | 30 Sep 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.21%
|
350,068
|
$4,439,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
287,601
|
$3,653,000 | — | 30 Sep 2022 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.17%
|
275,164
|
$3,495,000 | — | 30 Sep 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.16%
|
268,525
|
$3,410,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
266,581
|
$3,386,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.16%
|
263,026
|
$3,340,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
222,434
|
$2,825,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.13%
|
221,048
|
$2,807,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.13%
|
220,400
|
$2,799,000 | — | 30 Sep 2022 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.12%
|
200,000
|
$2,540,000 | — | 30 Sep 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.11%
|
176,490
|
$2,241,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
161,666
|
$2,053,000 | — | 30 Sep 2022 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.09%
|
155,095
|
$1,970,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.08%
|
137,737
|
$1,749,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
129,491
|
$1,645,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
126,578
|
$1,608,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
119,566
|
$1,518,000 | — | 30 Sep 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.07%
|
107,252
|
$1,362,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
104,900
|
$1,332,000 | — | 30 Sep 2022 | |
| HighVista Strategies LLC |
13F
|
Company |
0.06%
|
102,431
|
$1,301,000 | — | 30 Sep 2022 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.05%
|
89,793
|
$1,140,000 | — | 30 Sep 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.05%
|
82,420
|
$1,046,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
81,951
|
$1,041,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.04%
|
73,242
|
$930,000 | — | 30 Sep 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
64,910
|
$824,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
60,800
|
$772,000 | — | 30 Sep 2022 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.04%
|
58,207
|
$739,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
50,817
|
$645,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
48,818
|
$620,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.03%
|
44,270
|
$562,000 | — | 30 Sep 2022 |
Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q4 2022
As of 31 Dec 2022,
Dyne Therapeutics, Inc. - Common Stock (DYN) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,732,095 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, MPM ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, Deep Track Capital, LP, BlackRock Inc., WASATCH ADVISORS INC, EcoR1 Capital, LLC, Vida Ventures Advisors, LLC, Logos Global Management LP, and FRANKLIN RESOURCES INC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
100
Q4 2022 holders
112
Holder diff
12
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.